Emergent BioSolutions Inc.
Emergent BioSolutions Inc.（EBS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
ebs · 股价预测 · 15 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 15 位华尔街分析师
Buy
15 位分析师
共识
评级分布
12 个月目标价
High
$12.00
Consensus
$12.00
+50.0% upside
Low
$12.00
Median: $12 · Last Close: $8.00
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $7.80 | ↓ 2.49% |
1-day model range: $7.75–$7.85. Peak: $7.85 (-2.49%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $5 | -35.2% |
| 2028 | $4 | -47.8% |
| 2029 | $4 | -53.3% |
| 2030 | $4 | -56.1% |
| 2031 | — | -57.5% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · EBS · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-07 | Benchmark | Maintains | Buy→Buy |
| 2024-09-13 | Rodman & Renshaw | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Emergent BioSolutions Inc. (EBS) stock. Of the recent 66 rating actions, 5 were upgrades and 8 were downgrades. 15 analysts currently cover EBS.
分析师推荐趋势
EBS analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$809M
↓ 9.3% YoY
Revenue Next Year
$733M
↓ 9.4% YoY
EPS This Year
$2.05
EPS Next Year
$0.33
↓ 84.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast EBS EPS of $2.05 for the current fiscal year, based on estimates from 1 analysts. The EBS revenue forecast is $809M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
EBS 股价预测由两类独立数据源支撑：来自 15 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。EBS 的共识目标价为 $12.00（+50.0% 上行空间），分析师共识为 Buy。
EBS 的短期预测（明日）为 $7.80（-2.49%）。 EBS 对 2027 年的股价预测均值为 $5。 EBS 对 2030 年的预测区间为 $3–$4。
Emergent BioSolutions Inc. 在 NYSE 上市，代码 EBS。EBS 在 2027 年的整体展望偏积极，在覆盖分析师中约 73% 对应 Buy 共识。
常见问题
EBS 预测 · 8 个问题根据 15 位华尔街分析师，EBS 的 12 个月平均目标价为 $12.00，最高 $12.00、最低 $12.00。若有图表，中位目标价可在上方查看。相对当前价 $8.00，隐含约 +50.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.